Concepedia
Statistics
Publications
17
Citations
1.6K
H-Index
16
Active since
1992
Affiliations
Eli Lilly (United States)(Current)
St Vincents Institute of Medical Research
Institute for Cancer Prevention
North Carolina State University
Nalini H. Kulkarni is an author at Eli Lilly (United States) specializing in medicine, bone metabolism, and endocrinology.
Publications per year
1992–2010
Effects of parathyroid hormone on Wnt signaling pathway in bone
Nalini H. Kulkarni, David L. Halladay, Rebecca R. Miles et al. · Journal of Cellular Biochemistry · 2005 · 221 citations
Medicine, Endocrinology, Bone Metabolism +13
Orally Bioavailable GSK-3α/β Dual Inhibitor Increases Markers of Cellular Differentiation In Vitro and Bone Mass In Vivo
Nalini H. Kulkarni, Jude E. Onyia, Qingqiang Zeng et al. · Journal of Bone and Mineral Research · 2006 · 181 citations · Full text
Medicine, Endocrinology, Bone Metabolism +15
Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon.
Chinthalapally V. Rao, Dhimant Desai, Barbara Simi et al. · PubMed · 1993 · 181 citations
Medicine, Oncology, Pharmacology +17
Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds
Bandaru S. Reddy, Kenji Tokumo, Nalini H. Kulkarni et al. · Carcinogenesis · 1992 · 149 citations
Medicine, Oncology, Pharmacology +11
The genetic architecture of odor-guided behavior in Drosophila: epistasis and the transcriptome
Robert R. H. Anholt, Christy L Dilda, Sherman Chang et al. · Nature Genetics · 2003 · 140 citations
Life Sciences, Entomology, Genetics +14
1–5 of 17